Technical Analysis for ADAG - Adagene Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
D | 2.90 | 1.93% | 0.06 |
ADAG closed up 1.93 percent on Monday, March 18, 2024, on 8 percent of normal volume. The price action carved out a bullish hammer (or hammer-like) candlestick pattern. That may indicate an upside reversal. Look for price to trade above the high of the hammer for confirmation.
Earnings due: Mar 28
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Up | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Hammer Candlestick | Bullish | 0.00% | |
Stochastic Buy Signal | Bullish | 0.00% | |
Lizard Bullish | Bullish Day Trade Setup | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Outside Day | Range Expansion | 1.93% | |
Oversold Stochastic | Weakness | 1.93% | |
NR7 | Range Contraction | 1.40% | |
NR7-2 | Range Contraction | 1.40% | |
Stochastic Reached Oversold | Weakness | 1.40% | |
Oversold Stochastic | Weakness | 1.40% |
Alert | Time |
---|---|
10 DMA Resistance | about 20 hours ago |
Down 5% | about 20 hours ago |
Down 3% | about 20 hours ago |
Fell Below Previous Day's Low | about 20 hours ago |
Down 2 % | about 20 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 03/28/2024
Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel antibodies that address unmet patient needs. Its proprietary pipeline is comprised of novel immunotherapy programs. Adagene has forged strategic collaborations with reputable global partners that leverage its technology in multiple approaches at the vanguard of science.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Virotherapy Antibody Immunotherapies
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Artificial Intelligence Immunology Immunotherapy Antibodies Health Care Cancer Immunotherapy Virotherapy Antibody Immunotherapies
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 4.38 |
52 Week Low | 1.1001 |
Average Volume | 131,145 |
200-Day Moving Average | 1.89 |
50-Day Moving Average | 3.25 |
20-Day Moving Average | 3.08 |
10-Day Moving Average | 2.90 |
Average True Range | 0.31 |
RSI (14) | 44.44 |
ADX | 16.1 |
+DI | 10.33 |
-DI | 16.44 |
Chandelier Exit (Long, 3 ATRs) | 2.74 |
Chandelier Exit (Short, 3 ATRs) | 3.62 |
Upper Bollinger Bands | 3.49 |
Lower Bollinger Band | 2.67 |
Percent B (%b) | 0.28 |
BandWidth | 26.43 |
MACD Line | -0.10 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.0312 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 3.20 | ||||
Resistance 3 (R3) | 3.17 | 3.03 | 3.15 | ||
Resistance 2 (R2) | 3.03 | 2.96 | 3.05 | 3.13 | |
Resistance 1 (R1) | 2.97 | 2.91 | 3.00 | 3.00 | 3.12 |
Pivot Point | 2.83 | 2.83 | 2.85 | 2.85 | 2.83 |
Support 1 (S1) | 2.77 | 2.76 | 2.80 | 2.80 | 2.68 |
Support 2 (S2) | 2.63 | 2.71 | 2.65 | 2.67 | |
Support 3 (S3) | 2.57 | 2.63 | 2.65 | ||
Support 4 (S4) | 2.60 |